STOCKS

Technical signals suggest two of the most oversold stocks on the Nasdaq 100 are likely to underperform the broad markets, while two others appear to be good buys for after the ongoing correction.

The PowerShares QQQ Trust (QQQ), which tracks the Nasdaq 100 Index, was hit hard last week, declining 4.3% for the week, 1% worse than the Spyder Trust (SPY). QQQ is down 11.3% from the April 3 highs and closed last week just 0.6% above its weekly Starc- band.

Starc band analysis gives a reading of whether a stock is a high- or low-risk buy at the time. Close proximity to the upper Starc band (Starc+) means it is a high-risk time to buy since the stock is likely to at least move sideways, if not decline. Conversely, when a stock closes near its lower Starc band (Starc-), it is a high risk time to sell since the chances of a rebound are high.

For more on trading with Starc bands, click here.

The table below shows the 15 Nasdaq 100 stocks that are closest to their weekly Starc- bands. At the top of the list is Cisco Systems (CSCO), which closed last week 1.5% below its weekly Starc- band.

Just because a stock is oversold does not automatically make it a buy, as one needs to do further analysis to isolate those stocks that are in intermediate uptrends and where the relative performance analysis indicates they are outperforming the S&P 500.

chart
Click to Enlarge

The top two stocks on the list have chart patterns and technical readings that indicate their recent strength was just a rebound within the major downtrends. Two of the most oversold stocks do look like long term buys on a test of more important chart and Fibonacci retracement support.

chart
Click to Enlarge

Chart Analysis: Cisco Systems Inc. (CSCO) peaked at $27.74 in April 2010 and lost just over half its value by August 2011 when it made a low of $13.30. By early-April 2012, it has rebounded to $21.30, which was just above the major 50% Fibonacci retracement resistance at $20.52.

  • It is important to note the 61.8% retracement resistance at $22.23 was not exceeded, suggesting that the rally was just a rebound within the overall downtrend
  • CSCO plunged on May 10 in reaction to disappointing guidance in its earnings report
  • It is already down 22.7% from its highs and has been below its weekly Starc- band for the past two weeks
  • Next major support on the weekly chart, line a, is in the $15 area
  • As CSCO was moving higher, the relative performance, or RS analysis, was flat, line b. It has now dropped sharply, indicating CSCO is weaker than the S&P 500
  • On-balance-volume (OBV) has dropped below its weighted moving average (WMA) and failed to even reach the major resistance at line c
  • Near-term resistance for CSCO now stands at $18

Teva Pharmaceutical Industries (TEVA) is a $33 billion maker of generic drugs. TEVA closed below its uptrend, line d, two weeks ago, and is down 16% in the past three weeks. This completed the continuation pattern.

  • The rally from the 2011 lows just reached the major 38.2% Fibonacci retracement resistance from the 2010 high at $64.95
  • Next support is between $36.88 and $35
  • RS analysis declined, line e, as TEVA was moving higher. This was a sign of weakness, and it has continued to act weaker than the S&P 500
  • Weekly OBV is also in a longer-term downtrend, line f, suggesting that the buying was weak on the rally
  • There is first resistance for TEVA in the $41-$42 area

NEXT: 2 Good Buys for After the Correction

Tickers Mentioned: QQQ, CSCO, TEVA, SBUX, PCLN